By Susan Brinkmann, OCDS
Staff Journalist
Cardinal Daniel DiNardo, the chairman of the U.S. bishops’ Committee on Pro-Life Activities voiced “grave concern” to the U.S. Food and Drug Administration (FDA) over its move toward approving a new drug that may induce early abortions as an “emergency contraceptive.”
By Susan Brinkmann, OCDS
Staff Journalist
Less than a decade after the rush to make the “morning after pill”, known as Plan B, more widely available to women to prevent “unplanned pregnancies,” the failure of the drug now has the Food and Drug Administration (FDA) considering a new emergency contraceptive that studies show could be more effective in preventing pregnancy.
